Dignity’s net income in FY 2012, which ended June 30, totaled $132.5 million compared with $960.5 million in 2011. Net patient revenue crept up only 2.7 percent, from $9.3 billion last year to $9.6 billion this year.
Rising expenses accounted for part of Dignity’s lower profits, as total expenditures increased 4.2 percent year-over-year. In addition, Dignity lost a significant amount on investment income due to weak market conditions. In 2011, Dignity reported $717.9 million in investment income, but this year’s market yielded only $73.4 million in investment returns — a 90 percent drop.
In the year ended June 30, 2012, Dignity also recorded $769.7 million in cash and cash equivalents. Total assets equaled $5.66 billion.
More Articles on Dignity Health:
Ashland Community Hospital’s Board Approves Affiliation With Dignity Health
Dignity Health, Blue Shield ACO Saves California Retirement System $37M
Dignity Health Closes Acquisition of U.S. HealthWorks
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
